Guardian Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Guardian Partners's NVS Position: Q3 2026 in Review
Guardian Partners reduced its Novartis (NVS) stake by 5.5% in Q3 2026, selling an estimated $66.7K and leaving 7,525 shares worth $1.07M. The position accounts for 0.1% of the portfolio, ranked #117.
Guardian Partners first reported a position in NVS in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.25M in Q2 2026. 1,438 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Guardian Partners held 7,525 shares of Novartis worth $1.07M as of Q3 2026.
- Guardian Partners sold 440 Novartis shares in Q3 2026, an estimated $66.7K.
- Novartis made up 0.1% of Guardian Partners's portfolio in Q3 2026, its #117 holding.
- Guardian Partners first reported a position in Novartis in Q4 2024 and has held it in 8 quarters since.
- Guardian Partners's Novartis position peaked at $1.25M in Q2 2026.
- 1,438 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Guardian Partners's 13F filing for Q3 2026, filed 21 Oct 2026.